Literature DB >> 17876303

The complications of promiscuity: endocannabinoid action and metabolism.

S P H Alexander1, D A Kendall.   

Abstract

In this review, we present our understanding of the action and metabolism of endocannabinoids and related endogenous molecules. It is clear that the interactions between the multiple endocannabinoid-like molecules (ECLs) are highly complex, both at the level of signal transduction and metabolism. Thus, ECLs are a group of ligands active at 7-transmembrane and nuclear receptors, as well as transmitter-gated and ion channels. ECLs and their metabolites can converge on common endpoints (either metabolic or signalling) through contradictory or reinforcing pathways. We highlight the complexity of the endocannabinoid system, based on the promiscuous nature of ECLs and their metabolites, as well as the synthetic modulators of the endocannabinoid system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876303      PMCID: PMC2190010          DOI: 10.1038/sj.bjp.0707456

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  275 in total

1.  Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.

Authors:  T Sugiura; S Kondo; S Kishimoto; T Miyashita; S Nakane; T Kodaka; Y Suhara; H Takayama; K Waku
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

2.  Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels.

Authors:  B Y Ho; Y Uezono; S Takada; I Takase; F Izumi
Journal:  Receptors Channels       Date:  1999

3.  Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.

Authors:  A Jarrahian; S Manna; W S Edgemond; W B Campbell; C J Hillard
Journal:  J Neurochem       Date:  2000-06       Impact factor: 5.372

4.  Cannabinoids decrease the K(+) M-current in hippocampal CA1 neurons.

Authors:  P Schweitzer
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

5.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Authors:  Z Járai; J A Wagner; K Varga; K D Lake; D R Compton; B R Martin; A M Zimmer; T I Bonner; N E Buckley; E Mezey; R K Razdan; A Zimmer; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 6.  Oxidative metabolism of anandamide.

Authors:  S H Burstein; R G Rossetti; B Yagen; R B Zurier
Journal:  Prostaglandins Other Lipid Mediat       Date:  2000-04       Impact factor: 3.072

7.  AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun.

Authors:  B L Faubert; N E Kaminski
Journal:  J Leukoc Biol       Date:  2000-02       Impact factor: 4.962

8.  Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus.

Authors:  A F Hoffman; C R Lupica
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

9.  Stereoselective modulatory actions of oleamide on GABA(A) receptors and voltage-gated Na(+) channels in vitro: a putative endogenous ligand for depressant drug sites in CNS.

Authors:  B Verdon; J Zheng; R A Nicholson; C R Ganelli; G Lees
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

10.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

View more
  36 in total

Review 1.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

2.  Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Authors:  Vinogran Naidoo; David A Karanian; Subramanian K Vadivel; Johnathan R Locklear; JodiAnne T Wood; Mahmoud Nasr; Pamela Marie P Quizon; Emily E Graves; Vidyanand Shukla; Alexandros Makriyannis; Ben A Bahr
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

3.  Cannabinoids and their actions.

Authors:  S P H Alexander; M Randall
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

Review 4.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 5.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

Review 6.  A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.

Authors:  Rita Scarpelli; Oscar Sasso; Daniele Piomelli
Journal:  ChemMedChem       Date:  2015-10-21       Impact factor: 3.466

7.  Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity.

Authors:  A J Wheal; S P H Alexander; M D Randall
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 8.  Endothelial atypical cannabinoid receptor: do we have enough evidence?

Authors:  Alexander I Bondarenko
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

9.  Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development.

Authors:  Bruno M Fonseca; Georgina Correia-da-Silva; Anthony H Taylor; Justin C Konje; Stephen C Bell; Natércia A Teixeira
Journal:  Reprod Biol Endocrinol       Date:  2009-10-27       Impact factor: 5.211

Review 10.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.